在由BA和PFIC引起的儿科肝硬化中评估miRNA表达
Fatemeh Khosravi1, Ramin Yaghobi1, Afsoon Afshari2
1Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Fars Province, Iran, sums.ac.ir.
BioMed research international
|February 2, 2026
概括
儿科肝硬化患者的微RNA (miRNA) 水平不同,患有进展性家族性肝内胆固醇衰竭 (PFIC) 和胆道缩 (BA). 这些miRNA变化为儿科胆固醇和肝硬化提供了潜在的诊断和治疗见解.
科学领域:
- 分子生物学分子生物学
- 儿科胃肠病学 儿科胃肠病学
- 遗传学和基因组学 遗传学和基因组学
背景情况:
- 肝硬化是儿科胆固醇症死亡的主要原因.
- 微RNAs (miRNAs) 参与肝硬化病变的发生.
- 了解儿科肝硬化中的miRNA表达差异对于治疗和预后进步至关重要.
研究的目的:
- 调查和比较小儿科患者的miRNA表达特征肝硬化由于进展性家族性肝内胆固醇衰竭 (PFIC) 和胆道缩 (BA).
- 确定分子区别和miRNA调节在纤维化和肝硬化发展中的作用.
- 探索特定miRNAs作为诊断生物标记物和治疗点的潜力.
主要方法:
- 从43名被诊断患有肝硬化的PFIC和84名被诊断患有肝硬化的BA儿科患者收集了血液样本.
- 使用定量实时PCR (SYBR绿色RT-qPCR) 来评估12种特定miRNA的表达水平.
- 生物信息学工具被用来分析研究的miRNA及其相关信号通路 (PI3K/Akt,TGF-β) 的基因标.
主要成果:
- 所有12个miRNA都在肝硬化患者中表达更高,与健康对照组相比.
- 在PFIC和BA组之间观察到miRNA水平的显著差异:miR-34,miR-155,miR-199,miR-200b和miR-222在BA中更高,而miR-223在PFIC中更高.
- 与临床结果相关的特定miRNAs:miR-222与肝移植和BA中的PELD得分;miR-21,miR-155,miR-199,BA中的miR-200和PFIC中的miR-34与死亡率有关.
结论:
- 在儿科肝硬化中,在PFIC和BA之间存在明显的miRNA表达模式,突出了疾病特异性的分子机制.
- 某些miRNAs对疾病进展,肝移植和儿科肝硬化中的死亡率具有预测价值.
- 这些发现强调了miRNA表达和关键信号通路 (PI3K/Akt,TGF-β) 之间的联系,表明miRNA是儿童肝硬化潜在的治疗标和诊断工具.
相关概念视频
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
262
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
262
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
304
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
304
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
226
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
226
01:42What is Gene Expression?
196.7K
Overview
Gene expression is the process in which DNA directs the synthesis of functional products, that is, proteins. Cells can regulate gene expression at various stages. It allows organisms to generate different cell types and enables cells to adapt to internal and external factors.
Genetic Information Flows from DNA to RNA to Protein
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is made up of nucleotides and proteins consist of amino...
Gene expression is the process in which DNA directs the synthesis of functional products, that is, proteins. Cells can regulate gene expression at various stages. It allows organisms to generate different cell types and enables cells to adapt to internal and external factors.
Genetic Information Flows from DNA to RNA to Protein
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is made up of nucleotides and proteins consist of amino...
196.7K
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
296
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
296
02:48Expressing Solution Concentration
67.8K
A solute is a component of a solution that is typically present at a much lower concentration than the solvent. Solute concentrations are often described with qualitative terms such as dilute (of relatively low concentration) and concentrated (of relatively high concentration).
Concentrations may be quantitatively assessed using a wide variety of measurement units, each convenient for particular applications. Molarity (M) is a useful concentration unit for many applications in chemistry.
Concentrations may be quantitatively assessed using a wide variety of measurement units, each convenient for particular applications. Molarity (M) is a useful concentration unit for many applications in chemistry.
67.8K